CBx Sciences Releases Encapsulated Cannabinoid ‘Gems’ in Colorado

DENVER, Aug. 14, 2018 /PRNewswire/ — CBx Sciences, a CBx Enterprises brand, today announced the availability of its new Gems product line. Based on proven pharmaceutical delivery technology formulated by CBx Sciences Chief Scientist, Noel Palmer, Ph.D., Gems are small, discreet, lightly flavored lozenges that transmucosally deliver doses of potent cannabinoids, terpenes and complementary botanicals.

“Traditional cannabis edibles are subject to first pass metabolism which greatly reduces their efficacy, and makes reliable dosing nearly impossible,” explained Palmer. “With a proprietary cannabinoid encapsulation process, and delivery that eliminates first pass metabolism of cannabinoids, Gems delivers a

...read more at https://markets.businessinsider.com/news/stocks/cbx-sciences-releases-encapsulated-cannabinoid-gems-in-colorado-1027457071